SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-172962
Filing Date
2019-06-14
Accepted
2019-06-14 06:17:32
Documents
6
Period of Report
2019-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d766058d6k.htm 6-K 276638
2 GRAPHIC g766058g46l66.jpg GRAPHIC 7804
3 GRAPHIC g766058g88r99.jpg GRAPHIC 112622
4 GRAPHIC g766058img001.jpg GRAPHIC 224379
5 GRAPHIC g766058img002.jpg GRAPHIC 184054
6 GRAPHIC g766058img003.jpg GRAPHIC 160720
  Complete submission text file 0001193125-19-172962.txt   1222647
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 19897539
SIC: 2834 Pharmaceutical Preparations